CawachiTSE:2664 -0.71%62 Net Margin % is -0.38% as of Mar. 2026. GuruFocus rates TSE:2664 with a GF Score™ of 62/100 and a GF Value™ of 円2,712.48 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Cawachi ranks worse than 58.38% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Cawachi's Net Income for the
three
months ended in Mar. 2026 was 円-265 Mil. Cawachi's Revenue for the
three
months ended in Mar. 2026 was 円69,506 Mil. Therefore, Cawachi's net margin for the quarter that ended in Mar. 2026 was -0.38%.
The historical rank and industry rank for Cawachi's Net Margin % or its related term are showing as below:
TSE:2664'
s Net Margin % Range Over the Past 10 Years
Min: 0.76 Med: 1.46 Max: 2.5
Current: 1.13
TSE:2664's Net Margin % is ranked worse than 58.38% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs TSE:2664: 1.13
Cawachi (TSE:2664) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Cawachi Net Margin % Related Terms
Cawachi Net Margin % Historical Data
* Premium members only.
The historical data trend for Cawachi's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Cawachi's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cawachi Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cawachi's Net Margin % distribution charts can be found below:
* The bar in red indicates where Cawachi's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cawachi (TSE:2664) has a Net Margin % of -0.38% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Cawachi and its competitors. Over the past decade, Cawachi's Net Margin % has ranged from 0.76 to 2.50. According to the industry distribution chart, Cawachi ranks #390 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 58.4%.
Is Cawachi's Net Margin % too high?
Cawachi's current Net Margin % is -0.38%. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 2.50. Based on the distribution chart, Cawachi ranks #390 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cawachi has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cawachi's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Cawachi ranks #390 out of 668 companies for Net Margin %. This places Cawachi in the lower half of its industry. The industry median Net Margin % is 2.89. Historically, Cawachi's own Net Margin % has ranged from 0.76 to 2.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Cawachi and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cawachi's current Net Margin % is -0.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cawachi stock overvalued right now?
Based on GuruFocus' analysis, Cawachi (TSE:2664) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,712.48, compared to a current price of 円3,485.00 — trading 28.5% above its estimated fair value. The current Net Margin % is -0.38%. Cawachi's overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Cawachi (TSE:2664), the current Net Margin % is -0.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cawachi (TSE:2664) Overvalued in 2026?
Based on GuruFocus' analysis, Cawachi stock appears to be overvalued.
The current stock price of 円3,485.00 is trading 28.5% above its estimated GF Value™ of 円2,712.48.
GuruFocus considers Cawachi to be Modestly Overvalued.
Key valuation signals for TSE:2664:
Net Margin %: -0.38%
GF Value™: 円2,712.48 vs. price of 円3,485.00 (28.5% above fair value)
No single metric tells the full story. See the TSE:2664 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cawachi Ltd is a drug store operator based in Japan. The firm primarily sells pharmaceutical-related products to its customers. It also sells health foods, child care products, cosmetics, grocery, general food and confectionery through its retail outlets. The company operates over 300 stores across Japan.
62GF Score
Get the complete analysis for TSE:2664
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2664 has been successfully added to your 
